您好！欢迎来到上海怡恒生物科技有限公司！
冠状病毒 （CoV） 在各地很常见，是导致从普通感冒到中东呼吸系统综合症 （MERS） 和严重急性呼吸系统综合症 （SARS） 等各种病情的病毒大家族的一部分。从2020年，我们又面临着新型冠状病毒COVID-19，它迅速蔓延。新型冠状病毒COVID-19 对人类健康的潜在风险很高，造成的症状范围从轻微到严重病情，有的可能死亡。
Zeptometrix努力研究新型冠状病毒SARS-CoV-2，并为开发人员和实验室提供无危害使用、非传染性的外部质量控制品，Zeptometrix分子质控产品会为您的检验开发或研究分析研究提供一些帮助。
Zeptometrix提供各种新型冠状病毒质控品，其中为了针对高传染性的变种病毒，Zeptometrix生产了新型冠状病毒变种盘质控品（货号：NATSARS(COV2)-VP），包括四个单独的阿尔法、贝塔、伽玛和德尔塔新型冠状病毒变种。每个小瓶的目标含量为50,000 Copy/mL。
ZeptoMetrix 成立于 1999 年，总部位于纽约州布法罗市。它是设计、开发和向传染病诊断市场提供创新、高质量解决方案的行业供应商。Zeptometrix在分子诊断方面的知识和能力，包括外部质量控制品、验证面板、熟练度面板、定制和 OEM 产品/服务，使 ZeptoMetrix 成为第三方分子质控品的产品供应商。
| 病毒类型 | 种类 | 产品货号 | 产品叙述Zeptometrix | BSL Level | 其他信息 |
| SARS-CoV-2 |
Influenza A: A/Brisbane/10/07 Influenza B: B/Florida/02/06 RSVB: CH93(18)-18 SARS-COV-2: USA-WA1/2020 |
NATFRC-6C |
NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) |
|
非传染性无害的病毒质控品 |
| NATCV9-6C | NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) | 非传染性无害的病毒质控品 | |||
| NATRPC2.1-BIO | NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) | 非传染性无害的病毒质控品 | |||
| NATRVP2.1-BIO | NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) | 非传染性无害的病毒质控品 | |||
| NATRVP2-QIA | NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) | 非传染性无害的病毒质控品 | |||
|
Alpha (B.1.1.7) Beta (B.1.351) Delta (B.1.617.2) Gamma P.1) |
NATSARS(COV2)-VP | NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) | 非传染性无害的病毒质控品 | ||
| USA-WA1/2020 | NATSARS(COV2)-ERC | SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) | 非传染性无害的病毒质控品 | ||
| A-549 | NATSARS(COV2)-NEG | SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) | 非传染性无害的病毒质控品 | ||
| USA-WA1/2020 |
NATSARS(COV2)-ST |
SARS-Related Coronavirus 2 (SARS-CoV-2) Stock |
|
非传染性无害的病毒质控品 | |
| B.1.351 | NATSARS(COV2-SA)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) | 非传染性无害的病毒质控品 | ||
| B.1.1.7 | NATSARS(COV2-UK)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) | 非传染性无害的病毒质控品 | ||
| USA-WA1/2020 | 0810587 | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg) | BSL2 | 纯化中断灭活 | |
| USA-WA1/2020 | 0810587-0.5mg | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg) | BSL2 | 纯化中断灭活 | |
| USA-WA1/2020 | 0810587CFHI-0.5mL | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL) | BSL2 | 热灭活病毒培养液 | |
| USA-WA1/2020 | 0810587CFHI | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL) | BSL2 | 热灭活病毒培养液 | |
| USA-WA1/2020 | 0810587UV | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.1 Kappa | 0810623UV | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.1 Kappa | 0810623CFHI | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated) | BSL2 | 热灭活病毒培养液 | |
| B.1.617.2 Delta | 0810624UV | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.2 Delta | 0810624CFHI | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated) | BSL2 | 热灭活病毒培养液 | |
| Italy-INMI1 | 0810589CFHI | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | |
| Italy-INMI1 | 0810589UV | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| Hong Kong/VM20001061/2020 | 0810590CFHI | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | |
|
Hong Kong/VM20001061/2020 |
0810590UV | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
|
|
0810612CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | |
| B.1.1.7 | 0810612UV | SARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.351 | 0810613CFHI | SARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | |
|
B.1.351 |
0810613UV | SARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
|
B.1.1.7 |
0810614CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | |
| B.1.1.7 | 0810614UV | SARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| P1 | 0810616CFHI | SARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | |
| P1 | 0810616UV | SARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| 0820010CFHI | VeroE6 Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 | ||
| SARS-CoV-2 Recombinant | 0831042 | SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL) | BSL2 | Inactivated, Intact Bacterial Cells containing synthetic SARS-CoV-2 sequence. Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. | |
| 0831043 | SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x 1.0mL) | BSL2 | Inactivated, Intact Bacterial Cells containing synthetic SARS-CoV-2 sequence. Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 E gene and portions of the ORF1ab gene region. | ||
| SARS | 2003-00592 | NATSARS-ST | Coronavirus SARS Stock (Qualitative) (1 mL) | 非传染性无害的病毒质控品 | |
| Coronavirus | 229E | NATCOV(229E)-ST | Coronavirus 229E Stock (Qualitative) (1 mL) | 非传染性无害的病毒质控品 | |
| 229E |
0810229CF |
Coronavirus Strain: 229E Culture Fluid |
BSL2 | Titered Live Material MTA Required. |
|
| 229E |
0810229CFHI |
Coronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 |
|
|
| 229E | 0810229 | Coronavirus Strain: 229E Lysate | BSL2 | 纯化中断灭活 | |
| NL63 | NATCOV(NL63)-ST | Coronavirus NL63 Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| NL63 |
0810228CF |
Coronavirus Strain: NL63 Culture Fluid |
BSL2 |
Titered Live Material MTA Required. |
|
| NL63 |
0810228CFHI |
Coronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL) |
BSL2 | 热灭活病毒培养液 | |
| NL63 |
0810228 |
Coronavirus Strain: NL63 Lysate |
BSL2 | 纯化中断灭活 | |
| OC43 | NATCOV(OC43)-ST | Coronavirus OC43 Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| OC43 |
0810024CF |
Coronavirus Strain: OC43 Culture Fluid
|
BSL2 | Titered Live Material MTA Required. |
|
| OC43 |
0810024CFHI
|
Coronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL) |
BSL2 | 热灭活病毒培养液 | |
| OC43 | 0810024 | Coronavirus Strain: OC43 Lysate | BSL2 | 纯化中断灭活 | |
| MERS-CoV | Florida/USA-2_Saudi Arabia_2014 | NATMERS-ST | MERS-CoV Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| Florida/USA-2_Saudi Arabia_2014 |
0810575CF |
MERS-CoV (Strain: Florida/USA-2_Saudi Arabia_2014) Culture Fluid (1 mL)
|
BSL3 |
Live, MTA Required, BSL3 Lab Required. |
|
| Florida/USA-2_Saudi Arabia_2014 | 0810575CFHI | MERS-CoV (Strain: Florida/USA-2_Saudi Arabia_2014) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | 热灭活病毒培养液 |
